Immune Checkpoint Inhibitor Therapy and Risk of Tuberculosis Exacerbation

Immune checkpoint therapy with programmed cell death-1 (PD-1) inhibitors was linked to activation of latent Mycobacterium tuberculosis (Mtb) infection in 2 patients.

from Latest articles from Cancer Therapy Advisor News http://bit.ly/2WDSopq